Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer.

OBJECTIVE

We evaluated and compared two different experimental blood pool contrast agents for abdominal MR angiography in an animal model.

MATERIALS AND METHODS

In seven pigs, coronal T1-weighted three-dimensional fast field-echo images were obtained on a conventional 1.5-T MR imaging system before and after i.v. injection of the ultrasmall superparamagnetic iron oxide agent FeO-BPA. In another seven pigs, MR angiograms were acquired using the gadolinium polymer WIN 22181. Enhanced images were obtained 5-210 min after injection of FeO-BPA and 1-120 min after injection of WIN 22181.

RESULTS

Both blood pool agents yielded detailed angiograms of the abdominal vascular tree when imaging lasted 2 min. In-plane running vessels were imaged without saturation effects and with equivalent maximum signal-to-noise ratios. Half the maximum signal-to-noise ratio was reached 150 min after injection of FeO-BPA, whereas this interval was approximately 70 min for the gadolinium polymer. Because of these different imaging half-life periods, the effective diagnostic window provided by FeO-BPA was six to eight times longer than that of WIN 22181. In the liver, the vascular T1 shortening and the parenchymal T2* effect of FeO-BPA complemented each other, resulting in an optimal contrast-to-noise ratio significantly higher than that achieved with WIN 22181. This "double-contrast effect" in the liver was especially helpful when obtaining detailed MR portograms.

CONCLUSION

The blood pool agents FeO-BPA and WIN 22181 can be used to produce high-quality abdominal MR angiograms on standard MR imaging equipment. The contrast-to-noise ratio of hepatic vessels is best on iron oxide-enhanced images because of a T1-T2* synergistic effect in the liver. The longer diagnostic window provided by FeO-BPA coupled with the option of in-plane imaging suggests the usefulness of FeO-BPA in future MR imaging-guided vascular interventions.